Table 3 Percentages of splenocyte populations (CD45, CD4, CD8, CD197, CD62L, CD27, B220) in untreated BALB/c mice, treated with AA0029+Qs and immunised with AA0029+Qs+rFh15 and AA0029+Qs+rFh15b 2 weeks after immunisation schedule. Data presented as the mean ± standard error of the mean
Cell population | Untreated (%) | AA0029+Qs (%) | AA0029+Qs+rFh15 (%) | AA0029+Qs+rFh15b (%) |
|---|---|---|---|---|
CD45 | 75.7 ± 3.4 | 77.0 ± 0.7 | 75.5 ± 2.8 | 66.7 ± 1.3 |
CD4 | 21.1 ± 1.3 | 20.7 ± 0.4 | 21.3 ± 0.5 | 21.7 ± 4.0 |
CD8 | 8.4 ± 0.5 | 8.4 ± 0.6 | 10.2 ± 0.6 | 9.5 ± 1.3 |
CD197 | 16.9 ± 1.7 | 18.0 ± 2.1 | 12.6 ± 2.8 | 14.9 ± 0.6 |
CD62L | 23.2 ± 3.2 | 20.1 ± 5.0 | 17.2 ± 0.9 | 15.2 ± 5.0 |
CD27 | 19.4 ± 1.9 | 18.0 ± 1.6 | 16.9 ± 0.8 | 16.7 ± 3.6 |
B220 | 35.9 ± 3.2 | 39.4 ± 0.6 | 23.2 ± 1.7 | 21.3 ± 0.7* |